0,882  0,003  Caspase 3 stimulant
0,848  0,011  Apoptosis agonist
0,833  0,003  NOS2 expression inhibitor
0,793  0,002  Melanin inhibitor
0,755  0,009  Antileukemic
0,758  0,013  Antineoplastic (breast cancer)
0,761  0,016  Caspase 9 stimulant
0,706  0,005  Antineoplastic (glioma)
0,700  0,010  Chemopreventive
0,689  0,004  Antineoplastic (glioblastoma multiforme)
0,681  0,004  Skin whitener
0,658  0,005  CYP2C19 inhibitor
0,670  0,024  Transcription factor NF kappa B inhibitor
0,661  0,023  Antineoplastic (lung cancer)
0,656  0,018  Antineoplastic (colorectal cancer)
0,646  0,008  Antioxidant
0,654  0,017  Antineoplastic (colon cancer)
0,622  0,005  Antineoplastic (lymphoma)
0,626  0,010  Proliferative diseases treatment
0,627  0,015  Antihypercholesterolemic
0,614  0,010  Antiosteoporotic
0,606  0,005  Topoisomerase II inhibitor
0,604  0,015  Antineoplastic (ovarian cancer)
0,597  0,018  Prostate cancer treatment
0,591  0,015  Bone diseases treatment
0,563  0,010  Antiprotozoal (Leishmania)
0,542  0,013  Nitric oxide antagonist
0,527  0,010  Antimitotic
0,536  0,020  Antineoplastic (melanoma)
0,530  0,016  Antineoplastic (brain cancer)
0,518  0,023  Histamine release inhibitor
0,511  0,027  Respiratory analeptic
0,515  0,037  15-Lipoxygenase inhibitor
0,485  0,016  Antipyretic
0,495  0,028  5 Hydroxytryptamine release stimulant
0,481  0,018  Free radical scavenger
0,448  0,006  Protein-tyrosine phosphatase inhibitor
0,450  0,009  Genotoxic
0,446  0,013  Antineoplastic (lymphocytic leukemia)
0,436  0,004  Estrogen agonist
0,458  0,029  Hepatic disorders treatment
0,432  0,004  Estrogen receptor beta antagonist
0,438  0,010  Hepatoprotectant
0,431  0,005  Topoisomerase I inhibitor
0,429  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,445  0,022  CYP1A2 inhibitor
0,446  0,028  NOS3 expression inhibitor
0,430  0,018  Antineoplastic (renal cancer)
0,409  0,004  Estrogen antagonist
0,399  0,003  Estrogen receptor beta agonist
0,404  0,011  MAO inhibitor
0,407  0,021  Antihypertriglyceridemic
0,420  0,034  12-Lipoxygenase inhibitor
0,411  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,388  0,005  Alpha 2 adrenoreceptor antagonist
0,415  0,034  ICAM1 expression inhibitor
0,408  0,030  CYP3A4 inhibitor
0,377  0,006  Renal failure treatment
0,466  0,103  Antiinflammatory
0,367  0,005  Topoisomerase II alpha inhibitor
0,417  0,058  CYP3A4 substrate
0,364  0,005  Alpha 2c adrenoreceptor antagonist
0,386  0,030  Hypoglycemic
0,385  0,035  Sensitization
0,356  0,012  Amylase inhibitor
0,383  0,042  Cardioprotectant
0,413  0,073  TNF expression inhibitor
0,372  0,035  DNA damaging
0,436  0,100  Alpha-glucosidase inhibitor
0,363  0,029  Antineoplastic (small cell lung cancer)
0,376  0,044  Vasodilator, coronary
0,374  0,044  Analeptic
0,375  0,046  Spasmolytic
0,338  0,010  MAO B inhibitor
0,403  0,076  Antibacterial
0,374  0,048  AR expression inhibitor
0,334  0,011  Neurotrophic factor enhancer
0,329  0,008  Carcinogenic, group 1
0,363  0,043  Antineoplastic (cervical cancer)
0,366  0,049  Apoptosis antagonist
0,381  0,067  CYP2C9 inhibitor
0,318  0,008  Heat shock protein 90 antagonist
0,313  0,004  Postmenopausal disorders treatment
0,349  0,042  Cytostatic
0,319  0,019  Antineoplastic (squamous cell carcinoma)
0,320  0,020  VCAM1 expression inhibitor
0,350  0,051  Lipoxygenase inhibitor
0,367  0,078  Immunosuppressant
0,305  0,017  NOS3 expression enhancer
0,326  0,040  Vasodilator
0,329  0,048  Antineoplastic (non-small cell lung cancer)
0,299  0,019  Tubulin antagonist
0,282  0,003  Neuraminidase inhibitor
0,288  0,010  LDLR expression enhancer
0,341  0,064  Antifungal
0,283  0,007  Alpha 2a adrenoreceptor antagonist
0,320  0,062  CYP2D6 inhibitor
0,297  0,043  Antineoplastic (sarcoma)
0,309  0,060  Antineoplastic (multiple myeloma)
0,270  0,029  Prostatic (benign) hyperplasia treatment
0,292  0,053  Cytotoxic
0,258  0,019  Acetylcholinesterase inhibitor
0,241  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,271  0,038  Antiviral (Influenza)
0,301  0,069  Antineoplastic (osteosarcoma)
0,286  0,058  GST M1-1 substrate
0,344  0,120  5 Hydroxytryptamine release inhibitor
0,264  0,043  Abortion inducer
0,239  0,019  Psychosexual dysfunction treatment
0,237  0,021  CDC-like kinase 1 inhibitor
0,244  0,028  Lipid peroxidase inhibitor
0,237  0,024  Cyclooxygenase 1 inhibitor
0,274  0,061  Antiamyloidogenic
0,272  0,062  Vascular (periferal) disease treatment
0,247  0,039  CYP2B6 inhibitor
0,213  0,008  Carcinogenic, group 2A
0,208  0,004  Neuraminidase (influenza) inhibitor
0,209  0,006  CDC-like kinase 3 inhibitor
0,251  0,049  UDP-glucuronosyltransferase substrate
0,240  0,041  Antimutagenic
0,226  0,028  Monophenol monooxygenase inhibitor
0,261  0,067  Antineoplastic (liver cancer)
0,271  0,080  Lipoprotein disorders treatment
0,199  0,008  Estrogen receptor alpha antagonist
0,248  0,058  Amyloid beta aggregation inhibitor
0,210  0,022  Cystathionine beta-synthase inhibitor
0,222  0,037  Cholinergic
0,224  0,039  Antiviral (Herpes)
0,232  0,047  Nitric-oxide synthase stimulant
0,214  0,030  Antineoplastic (bone cancer)
0,258  0,079  UGT1A9 substrate
0,192  0,016  Antineoplastic alkaloid
0,200  0,025  DNA intercalator
0,197  0,023  Antihemorrhagic
0,263  0,089  CYP1A2 substrate
0,227  0,053  Pneumotoxic
0,213  0,040  Antineoplastic (carcinoma)
0,202  0,029  SULT1A3 substrate
0,221  0,052  P-glycoprotein inhibitor
0,264  0,096  CTGF expression inhibitor
0,265  0,098  CYP2D6 substrate
0,234  0,068  Antihypotensive
0,223  0,058  UGT1A1 substrate
0,205  0,041  UGT2B15 substrate
0,208  0,045  Acaricide
0,224  0,062  Carcinogenic
0,323  0,165  Antineoplastic (solid tumors)
0,169  0,013  Electron transport complex I inhibitor
0,215  0,063  Mutagenic
0,160  0,012  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,156  0,009  Alpha tubulin antagonist
0,197  0,051  Succinate dehydrogenase inhibitor
0,217  0,073  Pyruvate kinase inhibitor
0,242  0,098  Radioprotector
0,173  0,030  MAP kinase kinase 4 inhibitor
0,262  0,119  Vasodilator, peripheral
0,153  0,014  Macrophage migration inhibitory factor inhibitor
0,142  0,005  Estrogen receptor alpha agonist
0,150  0,014  Keratolytic
0,148  0,012  Antihypermotility
0,217  0,083  Cardiodepressant
0,154  0,019  DOPA decarboxylase inhibitor
0,165  0,031  Microtubule formation inhibitor
0,153  0,019  Histidine decarboxylase inhibitor
0,159  0,026  Antineoplastic (uterine cancer)
0,215  0,083  Cyclic AMP phosphodiesterase inhibitor
0,233  0,103  UGT2B4 substrate
0,145  0,016  Dopamine D1 antagonist
0,208  0,081  Antiparasitic
0,174  0,053  Protein kinase stimulant
0,226  0,106  Chemoprotective
0,181  0,062  UGT1A3 substrate
0,207  0,088  UGT1A6 substrate
0,221  0,102  Antiprotozoal (Trypanosoma)
0,143  0,028  Opioid antagonist
0,225  0,110  5 Hydroxytryptamine uptake stimulant
0,144  0,033  Antiviral (Influenza B)
0,229  0,118  Antihypoxic
0,168  0,060  UGT2B9 substrate
0,287  0,179  Alzheimer's disease treatment
0,184  0,077  Antihelmintic
0,112  0,006  Glutamate (mGluR7) antagonist
0,152  0,046  Cyclooxygenase 3 inhibitor
0,136  0,031  Creatine kinase inhibitor
0,144  0,039  Alpha adrenoreceptor antagonist
0,108  0,005  Endothelin receptor antagonist
0,105  0,003  Sodium/glucose cotransporter 2 inhibitor
0,175  0,073  UGT2B7 substrate
0,125  0,026  SULT1E1 substrate
0,100  0,004  Endothelin B receptor antagonist
0,116  0,021  Dopamine D3 antagonist
0,139  0,044  Alpha 2b adrenoreceptor antagonist
0,169  0,075  Phobic disorders treatment
0,104  0,013  Antitreponemal
0,199  0,110  Tumour necrosis factor alpha release inhibitor
0,110  0,024  Alpha adrenoreceptor agonist
0,095  0,010  Opioid kappa receptor agonist
0,177  0,095  Psychostimulant
0,084  0,003  Sodium/glucose cotransporter inhibitor
0,086  0,008  Acetyl-CoA transferase 2 inhibitor
0,121  0,045  Beta glucuronidase inhibitor
0,150  0,074  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,110  0,034  Ornithine decarboxylase inhibitor
0,141  0,066  Antifungal enhancer
0,147  0,073  Cyclooxygenase inhibitor
0,179  0,107  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,077  0,005  Endothelin A receptor antagonist
0,124  0,052  Glutathione S-transferase substrate
0,094  0,024  Beta tubulin antagonist
0,097  0,029  Lipase inhibitor
0,159  0,091  Antipruritic, non-allergic
0,178  0,111  5 Hydroxytryptamine 3E antagonist
0,076  0,010  Leukotriene C antagonist
0,118  0,053  MAO A inhibitor
0,075  0,011  Kinesin antagonist
0,075  0,011  Kinesin-like protein 1 inhibitor
0,142  0,078  Adenylate cyclase stimulant
0,099  0,037  Antiviral (Hepatitis A)
0,064  0,005  Dopamine autoreceptor agonist
0,123  0,066  DNA repair enzyme inhibitor
0,108  0,051  Antiadrenergic
0,105  0,051  Adrenaline antagonist
0,085  0,031  Glucagon-like peptide 1 agonist
0,094  0,041  mTOR complex 2 inhibitor
0,085  0,034  Dopamine agonist
0,071  0,020  Postcoital contraceptive
0,093  0,041  Dopamine antagonist
0,087  0,036  SULT1A2 substrate
0,154  0,103  Toxic, respiratory center
0,118  0,068  Alcohol dehydrogenase substrate
0,081  0,031  Leukotriene antagonist
0,092  0,043  Opioid kappa receptor antagonist
0,191  0,142  CYP2C19 substrate
0,096  0,046  ATPase (Vacuolar H+) inhibitor
0,072  0,027  Alpha 1 adrenoreceptor agonist
0,081  0,037  Leukotriene synthesis inhibitor
0,094  0,050  5 Hydroxytryptamine 2A antagonist
0,049  0,006  Estrogen-related receptor beta antagonist
0,082  0,039  Dopamine D2 antagonist
0,199  0,157  Prostaglandin dehydrogenase inhibitor
0,062  0,020  Topoisomerase II beta inhibitor
0,054  0,013  Nociceptin (N/OFQ) receptor antagonist
0,172  0,133  Cardiovascular analeptic
0,163  0,124  Dyrk kinase inhibitor
0,081  0,043  Histone deacetylase SIRT1 stimulant
0,081  0,043  Histone deacetylase stimulant
0,161  0,123  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,081  0,043  Glutamate decarboxylase inhibitor
0,061  0,026  Alpha-mannosidase inhibitor
0,092  0,058  Restless leg syndrome treatment
0,133  0,099  Sigma receptor agonist
0,113  0,079  Antiseptic
0,067  0,033  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,061  0,029  Opioid agonist
0,095  0,063  Phosphodiesterase 6D inhibitor
0,098  0,068  Carcinogenic, group 2B
0,095  0,066  Butyrylcholinesterase inhibitor
0,084  0,056  Acetylcholine M3 receptor agonist
0,180  0,153  DNA synthesis inhibitor
0,099  0,072  UGT2B1 substrate
0,133  0,106  Ca2+-transporting ATPase inhibitor
0,211  0,185  CYP2C9 substrate
0,053  0,028  Factor III inhibitor
0,139  0,115  Sedative
0,182  0,157  Renal disease treatment
0,220  0,197  Antiprotozoal
0,080  0,058  Phosphodiesterase 11A inhibitor
0,080  0,058  Phosphodiesterase XI inhibitor
0,104  0,083  Carcinogenic, group 3
0,227  0,206  Antiparkinsonian
0,030  0,011  Sodium/glucose cotransporter 1 inhibitor
0,080  0,061  Ca(v)3.1 blocker
0,131  0,115  Liver fibrosis treatment
0,137  0,121  Platelet adhesion inhibitor
0,084  0,069  Actinic keratosis treatment
0,129  0,116  Uterine stimulant
0,024  0,011  Imidazoline I1 receptor antagonist
0,097  0,084  SULT1A1 substrate
0,060  0,047  Protease activated receptor antagonist
0,045  0,032  Mannosidase inhibitor
0,090  0,078  Urease inhibitor
0,058  0,046  Adrenaline uptake inhibitor
0,075  0,064  Carbonic anhydrase VI inhibitor
0,060  0,049  Antiviral (Parainfluenza)
0,070  0,060  Na+ K+ transporting ATPase inhibitor
0,119  0,110  Acetylcholine M1 receptor antagonist
0,129  0,120  Prostate disorders treatment
0,039  0,030  Dopamine D5 agonist
0,076  0,067  Calcium antagonist
0,072  0,063  Antineoplastic antibiotic
0,197  0,189  GST A substrate
0,089  0,081  5 Hydroxytryptamine 2 antagonist
0,057  0,049  Ryanodine receptor antagonist
0,013  0,005  Imidazoline I2 receptor antagonist
0,053  0,046  Aromatase inhibitor
0,055  0,050  Heat shock protein 90 beta antagonist
0,022  0,017  Dopamine D1 agonist
0,065  0,060  SULT2A1 substrate
0,056  0,052  HIV-1 integrase (3'-Processing) inhibitor
0,067  0,065  NAD(P)H dehydrogenase (quinone) inhibitor

